Byondis
- Startpagina
- Nederland
- Nijmegen
- Byondis
Byondis is an independent biopharmaceutical research and development (R&D) company creating innovativ
Adres
Microweg 22
Nijmegen
6545CM
Openingstijden
| Maandag | 08:30 - 17:00 |
| Dinsdag | 09:00 - 17:00 |
| Woensdag | 08:30 - 17:00 |
| Donderdag | 09:00 - 17:00 |
| Vrijdag | 08:30 - 17:00 |
Telefoon
Website
Meldingen
Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Byondis nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.
Delen
We are Byondis
Built on exceptional science and driven to improve patients’ lives, Byondis is an independent biopharmaceutical research and development (R&D) company creating innovative precision medicines targeting intractable cancers and auto-immune diseases.
With its proprietary technologies, Byondis is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by unique molecular concepts, such as its linker-drug (LD) technology to generate antibody-drugconjugates (ADCs).
Byondis’ broad development portfolio comprises a spectrum of preclinical, early and late stage clinical programs, including the anti-HER2 ADC [vic-]trastuzumab duocarmazine (SYD985, Phase III). Process development and manufacturing capabilities for NBEs including ADCs are available up to (early) commercial launch.
Byondis has established long-term worldwide partnerships with global biotech and pharma companies and works in close collaboration with national and international academic research institutions.
